FDA Adverse Event Injury Summary report: N

WAVEWRITER ALPHA 16

MDR report key: 17481230 · Received August 8, 2023

Report

Report Number
3006630150-2023-04613
Event Type
Injury
Date Received
August 8, 2023
Date of Event
December 28, 2022
Report Date
March 5, 2025
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
LGW
UDI-DI
08714729985082
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: EXACT DATE UNKNOWN, EVENT OCCURRED IN APPROXIMATELY SEVERAL WEEKS ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT.

Additional Manufacturer Narrative · 0

BLOCK D6B: EXPLANT DATE: 2023. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS, UPN: M365SC2218500, MODEL: SC-2218-50, SERIAL: (B)(6) , BATCH: 7100292/7095544.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION. THE PATIENT UNDERWENT AN IPG EXPLANT PROCEDURE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION. THE PATIENT UNDERWENT AN IPG EXPLANT PROCEDURE. ADDITIONAL INFORMATION WAS RECEIVED THAT THE SPINAL CORD STIMULATION (SCS) LEADS WERE ALSO EXPLANTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION. THE PATIENT UNDERWENT AN IPG EXPLANT PROCEDURE. ADDITIONAL INFORMATION WAS RECEIVED THAT THE SPINAL CORD STIMULATION (SCS) LEADS WERE ALSO EXPLANTED. ADDITIONAL INFORMATION WAS RECEIVED THAT THE EXPLANTED DEVICES WERE NOT RETURNED AS NO BOSTON SCIENTIFIC REPRESENTATIVES WERE PRESENT DURING EXPLANT. NO FURTHER INFORMATION COULD BE OBTAINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2320385 WAVEWRITER ALPHA 16 STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SC-1216 527536 08714729985082

Patients

Seq Age Sex Outcome Treatment
1 74 YR Male Required Intervention